Kyung A Kang Selected Research

Biomarkers (Surrogate Marker)

2/2024	Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Naïve Patients With PI-RADS v2.1 Category 3 Lesions.
1/2016	MMP-14 Triggered Fluorescence Contrast Agent.
3/2006	Fluorophore-mediated, fiber-optic, multi-analyte, immunosensing system for rapid diagnosis and prognosis of cardiovascular diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung A Kang Research Topics

Disease

16	Neoplasms (Cancer) 09/2022 - 05/2002
10	Breast Neoplasms (Breast Cancer) 09/2022 - 05/2002
5	Hyperthermia 01/2013 - 01/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2008 - 01/2003
2	Adenoma (Adenomas) 02/2024 - 09/2023
2	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2008
2	Fatty Liver 09/2021 - 01/2020
2	Fibrosis (Cirrhosis) 09/2021 - 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Non-alcoholic Fatty Liver Disease 09/2021
1	Gallbladder Diseases (Gall Bladder Disease) 10/2020
1	Neoplasm Metastasis (Metastasis) 03/2020
1	Neoplasms, Cystic, Mucinous, and Serous 03/2020
1	Triple Negative Breast Neoplasms 01/2016
1	Nephrogenic Fibrosing Dermopathy 03/2015
1	Stomach Neoplasms (Stomach Cancer) 01/2013
1	Myocardial Infarction 01/2009
1	Blood Coagulation Disorders 01/2008
1	Coronary Disease (Coronary Heart Disease) 03/2006
1	Thrombosis (Thrombus) 01/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2003

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 09/2021 - 01/2011
4	GoldIBA 09/2015 - 01/2007
4	Contrast MediaIBA 01/2013 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2006
3	2-aminoethylmethacrylate (AEM)IBA 01/2013 - 01/2008
3	Protein CIBA 03/2006 - 01/2003
3	Hemoglobins (Hemoglobin)IBA 01/2005 - 05/2002
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2013 - 06/2011
2	factor V LeidenIBA 01/2008 - 01/2003
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2008 - 01/2008
1	LipidsIBA 02/2024
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2023
1	AldosteroneIBA 09/2023
1	AntigensIBA 09/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	Insulin (Novolin)FDA Link 01/2020
1	OligonucleotidesIBA 09/2015
1	AGRO 100IBA 09/2015
1	NucleolinIBA 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	gadolinium ethoxybenzyl DTPA FDA Link 03/2015
1	ferric oxide (iron oxide)IBA 01/2013
1	PolymersIBA 01/2013
1	Poloxamer (Poloxamer 407)IBA 01/2013
1	Green Fluorescent ProteinsIBA 01/2013
1	Factor V (Coagulation Factor V)IBA 01/2008
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2008
1	Amino Acids FDA Link 01/2008
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2008
1	Triptorelin Pamoate (Trelstar)FDA Link 01/2008
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2006
1	MyoglobinIBA 03/2006
1	Protein SIBA 03/2006
1	Troponin IIBA 03/2006
1	Antithrombin IIIIBA 03/2006
1	AnticoagulantsIBA 03/2006
1	C-Reactive ProteinIBA 03/2006
1	PlasminogenIBA 03/2006
1	Troponin T (Troponin T1)IBA 01/2003
1	Oxygen (Dioxygen)IBA 01/2003
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2007
2	Nanospheres 09/2015 - 01/2013
2	Micro-Electrical-Mechanical Systems 01/2009 - 01/2008
1	Drug Therapy (Chemotherapy) 01/2022
1	Cholecystectomy 10/2020
1	Pancreatectomy 03/2020
1	Induced Hyperthermia (Thermotherapy) 01/2008
1	Vascular Surgical Procedures 01/2003